At present, the precise mechanisms underlying OSM upregulation in NASH are uncertain and deserve further investigation, although it is possible that altered lipid metabolism or lipotoxicity may be involved [46]. This evidence concerns the gene OSM and metabolic dysfunction-associated steatohepatitis.